Beximco Pharmaceuticals Limited

DSE:BXPHARMA Stock Report

Market Cap: ৳35.6b

Beximco Pharmaceuticals Future Growth

Future criteria checks 3/6

Beximco Pharmaceuticals is forecast to grow earnings and revenue by 16.5% and 12.8% per annum respectively. EPS is expected to grow by 16.5% per annum. Return on equity is forecast to be 14.6% in 3 years.

Key information

16.5%

Earnings growth rate

16.5%

EPS growth rate

Pharmaceuticals earnings growth16.9%
Revenue growth rate12.8%
Future return on equity14.6%
Analyst coverage

Low

Last updated13 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DSE:BXPHARMA - Analysts future estimates and past financials data (BDT Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202764,4089,4736,4919,8461
6/30/202656,9098,0565,5768,6331
6/30/202550,2806,7324,7897,5451
9/30/202444,9465,9575,3917,353N/A
6/30/202444,3925,8306,1308,364N/A
3/31/202443,0855,3305,9628,373N/A
12/31/202341,6524,9165,6968,176N/A
9/30/202340,6394,7205,4868,109N/A
6/30/202339,2674,6143,4426,085N/A
3/31/202337,9744,4772,6505,562N/A
12/31/202237,3794,6291,3233,922N/A
9/30/202235,9875,1051,1613,910N/A
6/30/202234,6695,1232,2755,214N/A
3/31/202233,6605,7383,1435,950N/A
12/31/202132,0626,0974,1537,502N/A
9/30/202131,0375,5193,9836,796N/A
6/30/202129,4945,1283,4656,023N/A
3/31/202128,2694,5783,6675,592N/A
12/31/202027,5174,0172,1984,025N/A
9/30/202026,2353,7242,3544,895N/A
6/30/202025,6123,5153,2675,542N/A
3/31/202025,0563,405-1874,319N/A
12/31/201924,2023,2518345,814N/A
9/30/201923,7353,143-1144,397N/A
6/30/201922,8173,033-1,5852,960N/A
3/31/201921,7242,852-3002,893N/A
12/31/201820,1882,708-2,3931,397N/A
9/30/201818,8232,647-3,1061,611N/A
6/30/201817,7172,537N/A1,819N/A
3/31/201816,9242,513N/A2,416N/A
12/31/201716,5172,431N/A2,873N/A
9/30/201716,0222,356N/A2,643N/A
6/30/201715,5092,227N/A2,634N/A
3/31/201714,6872,224N/A2,042N/A
12/31/201614,2712,133N/A1,883N/A
9/30/201613,7362,060N/A1,932N/A
6/30/201613,3561,965N/A2,113N/A
12/31/201512,9661,954N/A1,835N/A
9/30/201512,5731,804N/A2,095N/A
6/30/201512,1341,813N/A1,937N/A
3/31/201511,6281,605N/A2,510N/A
12/31/201411,2071,528N/A2,216N/A
9/30/201411,1391,476N/A2,459N/A
6/30/201410,8471,471N/A2,146N/A
3/31/201410,8041,452N/A2,196N/A
12/31/201310,4911,405N/A2,130N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BXPHARMA's forecast earnings growth (16.5% per year) is above the savings rate (3.8%).

Earnings vs Market: BXPHARMA's earnings (16.5% per year) are forecast to grow faster than the BD market (15.1% per year).

High Growth Earnings: BXPHARMA's earnings are forecast to grow, but not significantly.

Revenue vs Market: BXPHARMA's revenue (12.8% per year) is forecast to grow faster than the BD market (9.3% per year).

High Growth Revenue: BXPHARMA's revenue (12.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BXPHARMA's Return on Equity is forecast to be low in 3 years time (14.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y